EUVIMEDEUVIMED entdecken
Crossref

The combination of very-small size proteoliposomes and alum is a safe adjuvant alternative for inducing anti-EGF antibodies: a preclinical study

Rodríguez Mabel Cruz, Báez Gretchen Bergado, Luna Yerandy Hechevarría, Fernández Diana Rosa Hernández, Palomo Addys González, Suárez Narjara González, Castillo Carlos Yordan González, Lorenzo María del Carmen Luzardo, García Lisset Chao, Ramírez Belinda Sánchez

Archives of Cancer Science and Therapy · 2022

DOI: 10.29328/journal.acst.1001029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Cancer Science and Therapy, 2022. Verfasst von Rodríguez Mabel Cruz und 9 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunization with human recombinant EGF chemically bound to the P64k protein of Neisseria meningitides (hrEGF-P64k) and adjuvanted in Montanide ISA 51 VG (Montanide) is an efficient strategy to induce polyclonal antibodies (PAbs) response targeting this self -antigen in cancer patients, which is the basis of the CIMAvax-EGF vaccine. The neutralizing potential of EGF-specific induced PAbs supports promising clinical data obtained to date with this vaccine. Herein, we evaluated a combination of very small-size proteoliposomes (VSSP) and aluminum hydroxide (Alum) as a novel adjuvant to induce specific PAbs with neutralizing and anti-proliferative properties on tumor cells, considering EGF as a model antigen. Toxicity at the injection site was not detected for the vaccine formulation containing VSSP/Alum, and it was immunogenic in BALB/c mice, as evidenced by the induction of high titers of EGF-specific polyclonal antibodies (PAbs). While schedule optimization increased the magnitude of the PAbs response induced by VSSP/Alum, induced PAbs’s avidity and intrinsic neutralizing potential were comparable to the humoral response induced by Montanide. Also, VSSP addition switched IgG subclasses distribution into a Th1-like pattern, as obtained with Montanide and desirable for a cancer vaccine. Finally, equivalent PAbs titers were induced by the vaccine formulations adjuvanted in VSSP/Alum or Montanide in tumor-bearing-mice, and immunosuppressed mice, suggesting the feasibility of the VSSP/Alum combined adjuvant for inducing anti-EGF antibodies in cancer patients at advanced stages of the disease.

Zitieren

APA

Cruz, R. M., Bergado, B. G., Hechevarría, L. Y., Hernández, F. D. R., González, P. A., González, S. N., González, C. C. Y., Luzardo, L. M. D. C., Chao, G. L., & Sánchez, R. B. (2022). The combination of very-small size proteoliposomes and alum is a safe adjuvant alternative for inducing anti-EGF antibodies: a preclinical study. Archives of Cancer Science and Therapy. https://doi.org/10.29328/journal.acst.1001029

Vancouver

Cruz RM, Bergado BG, Hechevarría LY, Hernández FDR, González PA, González SN, et al. The combination of very-small size proteoliposomes and alum is a safe adjuvant alternative for inducing anti-EGF antibodies: a preclinical study. Archives of Cancer Science and Therapy. 2022. doi:10.29328/journal.acst.1001029

BibTeX
@article{Cruz2022,
  author = {Cruz, Rodríguez Mabel and Bergado, Báez Gretchen and Hechevarría, Luna Yerandy and Hernández, Fernández Diana Rosa and González, Palomo Addys and González, Suárez Narjara and González, Castillo Carlos Yordan and Luzardo, Lorenzo María del Carmen and Chao, García Lisset and Sánchez, Ramírez Belinda},
  title = {The combination of very-small size proteoliposomes and alum is a safe adjuvant alternative for inducing anti-EGF antibodies: a preclinical study},
  journal = {Archives of Cancer Science and Therapy},
  year = {2022},
  doi = {10.29328/journal.acst.1001029}
}
Kostenlos starten →